| #153 |
Karin Iancu Ornstein |
Oracle |
1 |
| #153 |
Jeffrey David KEARNS |
Merrimack Pharmaceuticals |
1 |
| #153 |
Mark Spadafora |
Mide Technology |
1 |
| #153 |
Danna Rosenberg |
MIT |
1 |
| #153 |
Kalindi Parmar |
Dana-Farber Cancer Institute |
1 |
| #153 |
Andrew W. Fraley |
Modernatx |
1 |
| #153 |
Francois Mairesse |
Amazon |
1 |
| #153 |
Brig Barnum Elliott |
Bbn Technologies |
1 |
| #153 |
Robert T. Yu |
Eisai R&D Management Co. |
1 |
| #153 |
Robert Hess |
Thermo Fisher |
1 |
| #153 |
Joshua Goldshlag |
Ab Initio Technology |
1 |
| #153 |
A. David Boccuti |
Seventh Sense Biosystems |
1 |
| #153 |
Cindy Y. Fang |
MIT |
1 |
| #153 |
Anthony V. Catacchio |
Allen Medical Systems |
1 |
| #153 |
Andrea Iskenderian |
Shire Human Genetic Therapies |
1 |
| #153 |
Anton Deykoon |
Analogic |
1 |
| #153 |
Alfram V. Bright |
Tufts University |
1 |
| #153 |
Bret Alan Orner |
Schneider Electric It |
1 |
| #153 |
Paul M. English |
Kayak Software |
1 |
| #153 |
Julio H. Cuervo |
Sunesis Pharmaceuticals |
1 |
| #153 |
Furqan Nazeeri |
Pivot Solutions |
1 |
| #153 |
Steven J. Saul |
Charm Sciences |
1 |
| #153 |
Andrew K. Bolstad |
MIT |
1 |
| #153 |
Stephen Berasi |
Pfizer |
1 |
| #153 |
James Schoonmaker |
Smarter Systems |
1 |
| #153 |
Lorelei M. McCollum |
IBM |
1 |
| #153 |
Casey A. Maguire |
The General Hospital |
1 |
| #153 |
Bradley D. Olsen |
MIT |
1 |
| #153 |
Gert Blankenstein |
BOE |
1 |
| #153 |
Rezwanul Azim |
Verizon |
1 |
| #153 |
William H. Groves, Jr. |
Convergent Dental |
1 |
| #153 |
Katherine Taylor |
Shire Human Genetic Therapies |
1 |
| #153 |
Peter Jones |
Pfizer |
1 |
| #153 |
Richard Garner |
Osram Sylvania |
1 |
| #153 |
Jurgen Michel |
MIT |
1 |
| #153 |
Claudio Chuaqui |
Bristol-Myers Squibb |
1 |
| #153 |
Alkim Akyurtlu |
University Of Massachusetts |
1 |
| #153 |
Christophe Antczak |
Sloan Kettering Institute For Cancer Research |
1 |
| #153 |
Barbara A. Fox |
Dartmouth College |
1 |
| #153 |
I. Robert Silverman |
Concert Pharmaceuticals |
1 |
| #153 |
Marc Nahmani |
Brandeis University |
1 |
| #153 |
Brian Cali |
Ironwood Pharmaceuticals |
1 |
| #153 |
Paul Joseph Vozila |
Microsoft |
1 |
| #153 |
Shyamala A. Subramanian |
E Ink Holdings |
1 |
| #153 |
Albert Hopeman |
Oracle |
1 |
| #153 |
Stephen Opie |
The Timberland |
1 |
| #153 |
Bryan S. Robinson |
MIT |
1 |
| #153 |
Wender Wang |
Thermacell Repellents |
1 |
| #153 |
Michael Zimmer |
The General Hospital |
1 |
| #153 |
Samuel Shian |
Harvard University |
1 |